CSS
NRC icon

Cubist Systematic Strategies’s NRC Health Common Stock NRC Stock Holding History

Cubist Systematic Strategies’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,184
Closed -$118K – 3349
2025
Q1 		$118K Buy
+9,184
New +$147K ﹤0.01% 2618
2024
Q4 		– Sell
-12,451
Closed -$285K – 3366
2024
Q3 		$285K Sell
12,451
-9,836
-44% -$222K ﹤0.01% 2451
2024
Q2 		$511K Buy
22,287
+6,398
+40% +$197K ﹤0.01% 2112
2024
Q1 		$629K Buy
+15,889
New +$628K ﹤0.01% 2487
2022
Q1 		– Sell
-6,249
Closed -$259K – 3707
2021
Q4 		$259K Buy
+6,249
New +$272K ﹤0.01% 2904
2020
Q3 		– Sell
-3,868
Closed -$225K – 2584
2020
Q2 		$225K Buy
+3,868
New +$204K ﹤0.01% 1983
2020
Q1 		– Sell
-1,685
Closed -$111K – 2342
2019
Q4 		$111K Buy
+1,685
New +$103K ﹤0.01% 2175

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Cubist Systematic Strategies's NRC Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of NRC Health Common Stock (NRC) in Q2 2025, closing a stake of 9,184 shares — an estimated $118K sold.

Cubist Systematic Strategies first reported a position in NRC in Q4 2019 and held it in 7 quarters. The position peaked at $629K in Q1 2024. 126 funds tracked by Wall St. Rank hold NRC as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining NRC Health Common Stock position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 9,184 NRC Health Common Stock shares in Q2 2025, an estimated $118K.
  • Cubist Systematic Strategies first reported a position in NRC Health Common Stock in Q4 2019 and held it in 7 quarters.
  • Cubist Systematic Strategies's NRC Health Common Stock position peaked at $629K in Q1 2024.
  • 126 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.